FDA Drug Application (022249) for TREANDA by CEPHALON

Back to FDA Applications sponsored by CEPHALON

Application Number022249
Product Number001
FormPOWDER;IV (INFUSION)
Dosage100MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameTREANDA
Active IngredientBENDAMUSTINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient BENDAMUSTINE HYDROCHLORIDE3


Back to FDA Applications sponsored by CEPHALON